Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PIOGLITAZONE HYDROCHLORIDE USP, with a corresponding US DMF Number 27504.
Remarkably, this DMF maintains an Active status since its submission on September 19, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 21, 2014, and payment made on September 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II